ClinicalTrials.Veeva

Menu

High Flow Nasal Oxygen for Acute Hypoxemic Respiratory Failure in the Emergency Room (GLAMOUR)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Not yet enrolling

Conditions

Respiratory Distress Syndrome, Adult

Treatments

Other: standard oxygen
Device: high flow nasal cannula

Study type

Interventional

Funder types

Other

Identifiers

NCT06489379
6697 (Other Identifier)

Details and patient eligibility

About

The aim of this multicenter, randomized, controlled, open-label trial is to investigate the efficacy of early treatment with HFNO compared with SOT in preventing early deterioration of patients admitted to the ER because of acute hypoxemic respiratory failure.

Enrollment

234 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years;
  • PaO2/FiO2 ratio between 250 and 150 mmHg or SpO2/FiO2 ratio between 190 and 274, after at least 15 minutes of spontaneous breathing through a Venturi mask (VM), with a FiO2 targeted at a SpO2 94-97%;
  • Respiratory rate(RR)≤35breaths/min,afteratleast15minutesofspontaneous breathing through a VM, with a FiO2 targeted at a SpO2 94-97%;
  • PaCO2 ≤ 45 mmHg;
  • Unilateral or bilateral infiltrate(s), as detected with chest radiography and/or computed tomography and/or with lung ultrasound not fully explained by effusions, atelectasis, or nodules/masses. Infiltrates at lung ultrasound are defined as presence of focal B-lines, consolidations (with irregular marginal contour, air bronchogram, air trapping sign) and irregularity of the pleural line.

Exclusion criteria

  • Respiratory failure due to:

    • Acute asthma or COPD exacerbation,
    • Cardiac failure or fluid overload as primary cause of respiratory failure;
  • Unstable angina or ongoing acute myocardial infarction;

  • Acute respiratory acidosis with pH < 7.35 and PaCO2 > 45 mmHg;

  • Hemodynamic instability and/or use of vasopressors/inotropes;

  • Altered mental status (Kelly >3), see Figure 1;(18)

  • Contraindications to NIV (high risk of aspiration pneumonia, impaired airways protection, head-facial trauma and/or burns, uncooperative patient, cranial/thoracic/abdominal open wounds);

  • Indications to urgent intubation performed according to the clinician in charge;

  • Body Mass Index > 35 kg/m2;

  • Pregnancy;

  • Patient's refusal to participate.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

234 participants in 2 patient groups

standard oxygen
Active Comparator group
Treatment:
Other: standard oxygen
high flow nasal oxygen
Experimental group
Treatment:
Device: high flow nasal cannula

Trial contacts and locations

0

Loading...

Central trial contact

Francesco Franceschi, MD; Gianluca Tullo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems